Nachrichten zur Moderna Aktie

Covid-Impfstoffhersteller Moderna bekommt sinkende Nachfrage zu spüren

CAMBRIDGE (dpa-AFX) - Das Biotechunternehmen Moderna bekommt die sinkende Nachfrage nach seinem Covid-19-Impfstoff zu spüren.…

Moderna-Aktie vorbörslich an der NASDAQ in Grün: Moderna mit rückläufigem Gewinn und Umsatz - Erwartungen dennoch übertroffen

Der Impfstoffhersteller Moderna hat seine Bilanz offen gelegt....…

Moderna-Aktie vorbörslich an der NASDAQ in Rot: Moderna mit rückläufigem Gewinn und Umsatz - Erwartungen dennoch übertroffen

Der Impfstoffhersteller Moderna hat seine Bilanz offen gelegt....…

ModernaTX, Inc: Moderna Reports First Quarter 2023 Financial Results and Provides Business Updates

First quarter 2023 revenues of $1.9 billion; GAAP net income of $79 million and GAAP diluted EPS of $0.19Company in…

UPDATE 1-Moderna beats COVID vaccine sales expectations as deferred revenue rolls in

...(Adds shares) By Patrick Wingrove and Leroy Leo May 4 (Reuters... Reuters. Moderna continues to expect the U.S. annual COVID-19 market......…

Moderna stock up premarket after posting surprise profit and revenue that crushed estimates

Moderna Inc.’s stock MRNA rose 1.8% premarket Thursday, after the biotech blew past estimates for first-quarter earnings, even as profit…

Moderna beats COVID vaccine sales expectations as deferred revenue rolls in

...By Patrick Wingrove and Leroy Leo (Reuters) - Moderna Inc...," Moderna Chief Commercial Officer Arpa…

Form 8-K Moderna, Inc. For: May 04

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna GAAP EPS of $0.19 beats by $1.94, revenue of $1.9B beats by $730M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna, Inc.: Moderna Announces Phase 1/2 Data on mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia to be Presented at the 2023 ASGCT Annual Meeting

After completing enrollment in 5 dose cohorts, and with no dose-limiting safety signals observed to date by the independent DSMB,…

Moderna Reports Earnings. What Comes After Covid Vaccine Will Be the Focus.

As the biotech reports first-quarter earnings, the focus will be on Moderna's pipeline of future vaccines and cancer treatments and…

FDA approves GSKs RSV vaccine for older adults, worlds first shot against virus

The FDAs approval is a victory for GSK in a race against Pfizer and Moderna to bring a shot that…

All eyes on Moderna Q1 earnings with focus on pipeline beyond COVID

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Should You Buy Moderna (MRNA) Ahead of Earnings?

Moderna (MRNA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....…

Moderna plans to open an enterprise solutions hub in the Philippines

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna, Inc.: Moderna Announces Establishment of an Enterprise Solutions Hub and Commercial Operations in The Philippines

The Enterprise Solutions Hub in the Philippines will support the Asia Pacific region and complements Modernas Enterprise Solutions Hubs in…

The Zacks Analyst Blog Highlights Advanced Micro Devices, The Cigna Group, Moderna, Parker-Hannifin and Rollins

Advanced Micro Devices, The Cigna Group, Moderna, Parker-Hannifin and Rollins are included in this Analyst Blog....…

Insiderhandel: Chief Executive Officer verkauft Aktien von Moderna im Wert von 5.269.140$

Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-04-26...…

Insiderhandel: Chief Executive Officer verkauft Aktien von Moderna im Wert von 5.224.570$

Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-04-27...…

Moderna (MRNA) to Report Q1 Earnings: Will It Beat Estimates?

Investors focus will likely be on Modernas (MRNA) pipeline, especially its late-stage pipeline candidates, when it reports first-quarter earnings....…

Better Healthcare AI Buy: Moderna vs. Medronic

Both of these companies are putting the focus on AI....…

Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know

Moderna (MRNA) closed the most recent trading day at $130.07, moving -0.5% from the previous trading session....…

Second judge says US not liable in Moderna COVID-19 vaccine patent case

...By Blake Brittain (Reuters) - Moderna Inc failed to persuade......…

$100 Invested In Moderna 5 Years Ago Would Be Worth This Much Today

Better Buy: Pfizer vs. Moderna

Pfizer and Moderna each have lost more than 20% since the start of the year....…

Moderna: Covid bleibt ein wichtiger kurzfristiger Treiber - Aktienanalyse

New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Analyst Evan Wang von Guggenheim Securities: Evan Wang, Analyst von Guggenheim Securities, leitet die Coverage…

Mehr als BioNTech, Moderna und Co

Der Weltgesundheitsmarkt wächst stetig. Innovative biotechnologische Ansätze und die fortschreitende Digitalisierung werden in den kommenden Jahren den Gesundheitsmarkt auf den…

Is Moderna Setting Expectations Too High?

The company may be overly optimistic when it comes to its outlook....…

How To Attend Moderna Q1 2023 Earnings Conference Call

Can This AI Deal With IBM Be a Game-Changer for Moderna?

Moderna has already been using AI inside and outside of the lab....…

Moderna CEO Stephane Bancel sits down one-on-one with Jim Cramer

Stephane Bancel, CEO of Moderna, joins "Mad Money" host Jim Cramer to discuss the company's goals to expand vaccine production…

Insiderhandel: Chief Executive Officer verkauft Aktien von Moderna im Wert von 5.719.539$

Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-04-20...…

Insiderhandel: Chief Executive Officer verkauft Aktien von Moderna im Wert von 5.715.262$

Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-04-19...…

Moderna, Inc.: Moderna to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023

CAMBRIDGE, MA / ACCESSWIRE / April 20, 2023 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics…

Moderna, IBM to use quantum computing, AI for mRNA research

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna teams up with IBM to put AI, quantum computing to work on mRNA technology used in vaccines

Modernas partnership with IBM comes as the drugmaker navigates its post-pandemic boom driven by its mRNA Covid vaccine. ...…

Moderna Partners With IBM Hoping AI Can Help Develop More mRNA Medicine

Modernas CEO said the partnership will allow the company to advance and accelerate its mRNA research and help it build…

Moderna Teams With IBM to Explore AI, Quantum Computing in Vaccine Development

Moderna Teams With IBM to Explore AI, Quantum Computing in Vaccine Development...…

Moderna, Inc.: Moderna and IBM to Explore Quantum Computing and Generative AI for mRNA Science

Moderna invests in developing quantum computing skills and exploring the use of quantum computing in developing future mRNA medicinesAgreement with…

Is Moderna About to Face the Same Challenge as Other Biotechs?

Investors have gotten used to Modernas rapid vaccine development....…

Moderna (MRNA) Gains As Market Dips: What You Should Know

In the latest trading session, Moderna (MRNA) closed at $142.82, marking a +0.13% move from the previous day....…

Moderna Stock: Bear vs. Bull

Moderna shares have delivered big for early investors....…

FDA Authorizes Changes To Simplify Use Of Moderna, Pfizer Bivalent COVID-19 Vaccines

NEW YORK CITY (dpa-AFX) - The U.S. Food and Drug Administration said it has amended the emergency use authorizations or…

FDA Authorizes Changes To Simplify Use Of Moderna, Pfizer Bivalent COVID-19 Vaccines

The U.S. Food and Drug Administration said it has amended the emergency use authorizations or EUAs of COVID-19 bivalent mRNA…

Moderna Inc. stock outperforms competitors despite losses on the day

Moderna Inc. stock outperforms competitors despite losses on the day...…

Tuesday’s Top Analyst Upgrades and Downgrades: Boston Scientific, GM, JPMorgan, Match, Moderna, Snap, Uber, Wells Fargo and More

Tuesdays top analyst upgrades and downgrades included Agilon Health, Boston Scientific, General Motors, JPMorgan Chase, Match, Moderna, Okta, Palo Alto…

dpa-AFX ProFeed